NKG2D performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d

European Journal of Immunology

Volumn 41, Issue 7, 2011, Pages 1913-1923

  Kuylenstierna, Carlotta ^a   Björkström, Niklas K ^a   Andersson, Sofia K ^a   Sahlström, Peter ^a   Bosnjak, Lidija ^a   Paquin Proulx, Dominic ^a   Malmberg, Karl Johan ^a   Ljunggren, Hans Gustaf ^a   Moll, Markus ^a   Sandberg, Johan K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD1d; Innate immunity; NK cells; NKT cells

Indexed keywords

CD1D ANTIGEN; CD3 ANTIBODY; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DEGRANULATION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD1D; ANTIGENS, CD4; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; K562 CELLS; LYMPHOCYTE ACTIVATION; MICE; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PERFORIN; RECEPTORS, ANTIGEN, T-CELL;

EID: 79959755773     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940278     Document Type: Article

References (57)

1. Bendelac, A., Savage, P. B. and Teyton, L., The biology of NKT cells. Annu. Rev. Immunol. 2007. 25: 297-336.
2. Godfrey, D. I. and Kronenberg, M., Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004. 114: 1379-1388.
3. van Der Vliet, H. J., Nishi, N., de Gruijl, T. D., von Blomberg, B. M., van den Eertwegh, A. J., Pinedo, H. M., Giaccone, G. et al., Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 2000. 95: 2440-2442.
4. + alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7. Proc. Natl. Acad. Sci. USA 2004. 101: 7058-7063.
5. Sandberg, J. K., Bhardwaj, N. and Nixon, D. F., Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT-cell compartment. Eur. J. Immunol. 2003. 33: 588-596.
6. Dougan, S. K., Kaser, A. and Blumberg, R. S., CD1 expression on antigen-presenting cells. Curr. Top. Microbiol. Immunol. 2007. 314: 113-141.
7. Stronge, V. S., Salio, M., Jones, E. Y. and Cerundolo, V., A closer look at CD1d molecules: new horizons in studying NKT cells. Trends Immunol. 2007. 28: 455-462.
8. Smed-Sorensen, A., Moll, M., Cheng, T. Y., Lore, K., Norlin, A. C., Perbeck, L., Moody, D. B. et al., IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. Blood 2008. 111: 5037-5046.
9. Brutkiewicz, R. R., CD1d ligands: the good, the bad, and the ugly. J. Immunol. 2006. 177: 769-775.
10. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B., Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003. 4: 1230-1237.
11. Nagarajan, N. A. and Kronenberg, M., Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 2007. 178: 2706-2713.
12. Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H. W., Loza, M. J., Perussia, B., Kronenberg, M. et al., Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK-cells. J. Immunol. 2001. 167: 3114-3122.
13. Nieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R. et al., Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004. 103: 383-389.
14. Smyth, M. J., Wallace, M. E., Nutt, S. L., Yagita, H., Godfrey, D. I. and Hayakawa, Y., Sequential activation of NKT cells and NK-cells provides effective innate immunotherapy of cancer. J. Exp. Med. 2005. 201: 1973-1985.
15. Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P. et al., CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 2003. 197: 1051-1057.
16. Swann, J. B., Coquet, J. M., Smyth, M. J. and Godfrey, D. I., CD1-restricted T cells and tumor immunity. Curr. Topl Microbiol. Immunol. 2007. 314: 293-323.
17. Yamamura, T., Sakuishi, K., Illes, Z. and Miyake, S., Understanding the behavior of invariant NKT cells in autoimmune diseases. J. Neuroimmunol. 2007. 191: 8-15.
18. Meyer, E. H., DeKruyff, R. H. and Umetsu, D. T., iNKT cells in allergic disease. Curr. Top. Microbiol. Immunol. 2007. 314: 269-291.
19. Diana, J. and Lehuen, A., NKT cells: friend or foe during viral infections? Eur. J. Immunol. 2009. 39: 3283-3291.
20. Tupin, E., Kinjo, Y. and Kronenberg, M., The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007. 5: 405-417.
21. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625-636.
22. Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002. 195: 637-641.
23. + invariant NKT cells. Blood 2007. 110: 251-258.
24. Chen, X., Wang, X., Besra, G. S. and Gumperz, J. E., Modulation of CD1d-restricted NKT-cell responses by CD4. J. Leukoc. Biol. 2007. 82: 1455-1465.
25. Eger, K. A., Sundrud, M. S., Motsinger, A. A., Tseng, M., Van Kaer, L. and Unutmaz, D., Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions. PLoS One 2006. 1: e50.
26. Gonzalez, S., Lopez-Soto, A., Suarez-Alvarez, B., Lopez-Vazquez, A. and Lopez-Larrea, C., NKG2D ligands: key targets of the immune response. Trends Immunol. 2008. 29: 397-403.
27. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003. 281: 65-78.
28. Gonzalez, V. D., Bjorkstrom, N. K., Malmberg, K. J., Moll, M., Kuylenstierna, C., Michaelsson, J., Ljunggren, H. G. et al., Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets. J. Immunol. Methods 2008. 330: 64-74.
29. Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C. T., Spies, T. and Bukowski, J. F., MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 2001. 15: 83-93.
30. Fasth, A. E., Bjorkstrom, N. K., Anthoni, M., Malmberg, K. J. and Malmstrom, V., Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis. Eur. J. Immunol. 2010. 40: 378-387.
31. Song, L., Asgharzadeh, S., Salo, J., Engell, K., Wu, H. W., Sposto, R., Ara, T. et al., Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J. Clin. Invest. 2009. 119: 1524-1536.
32. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H. and Godfrey, D. I., NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 2002. 14: 165-171.
33. Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I. et al., Critical contribution of IFN-gamma and NK-cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur. J. Immunol. 2001. 31: 1720-1727.
34. Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H. et al., Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002. 99: 1259-1266.
35. Smyth, M. J., Thia, K. Y., Street, S. E., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T. et al., Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 2000. 191: 661-668.
36. Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S. et al., NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008. 28: 571-580.
37. Ljunggren, H. G., Cancer immunosurveillance: NKG2D breaks cover. Immunity 2008. 28: 492-494.
38. Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y. et al., Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res. 1999. 59: 5102-5105.
39. Tahir, S. M., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P. et al., Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J. Immunol. 2001. 167: 4046-4050.
40. Fujii, S., Shimizu, K., Klimek, V., Geller, M. D., Nimer, S. D. and Dhodapkar, M. V., Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes. Br. J. Haematol. 2003. 122: 617-622.
41. Molling, J. W., Kolgen, W., van der Vliet, H. J., Boomsma, M. F., Kruizenga, H., Smorenburg, C. H., Molenkamp, B. et al., Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT-cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int. J. Cancer 2005. 116: 87-93.
42. Dhodapkar, M. V., Geller, M. D., Chang, D. H., Shimizu, K., Fujii, S., Dhodapkar, K. M. and Krasovsky, J., A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J. Exp. Med. 2003. 197: 1667-1676.
43. Giaccone, G., Punt, C. J., Ando, Y., Ruijter, R., Nishi, N., Peters, M., von Blomberg, B. M. et al., A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 2002. 8: 3702-3709.
44. Ishikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T. et al., A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 2005. 11: 1910-1917.
45. Ljunggren, H. G. and Malmberg, K. J., Prospects for the use of NK-cells in immunotherapy of human cancer. Nat. Rev. Immunol. 2007. 7: 329-339.
46. Moll, M., Andersson, S. K., Smed-Sorensen, A. and Sandberg, J. K., Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 2010. 116: 1876-1884.
47. Yuan, W., Dasgupta, A. and Cresswell, P., Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat. Immunol. 2006. 7: 835-842.
48. Schepis, D., D'Amato, M., Studahl, M., Bergstrom, T., Karre, K. and Berg, L., Herpes simplex virus infection downmodulates NKG2D ligand expression. Scand. J. Immunol. 2009. 69: 429-436.
49. Ward, J., Bonaparte, M., Sacks, J., Guterman, J., Fogli, M., Mavilio, D. and Barker, E., HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007. 110: 1207-1214.
50. Cerboni, C., Neri, F., Casartelli, N., Zingoni, A., Cosman, D., Rossi, P., Santoni, A. et al., Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 2007. 88: 242-250.
51. + T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 2008. 4: e1000101.
52. Sandberg, J. K., Fast, N. M., Palacios, E. H., Fennelly, G., Dobroszycki, J., Palumbo, P., Wiznia, A. et al., Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 2002. 76: 7528-7534.
53. Moll, M., Kuylenstierna, C., Gonzalez, V. D., Andersson, S. K., Bosnjak, L., Sonnerborg, A., Quigley, M. F. et al., Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection. Eur. J. Immunol. 2009. 39: 902-911.
54. Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L. et al., Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 2006. 203: 1343-1355.
55. Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H. et al., Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004. 21: 357-366.
56. Bjorkstrom, N. K., Gonzalez, V. D., Malmberg, K. J., Falconer, K., Alaeus, A., Nowak, G., Jorns, C. et al., Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK-cell-like function in chronic hepatitis C virus infection. J. Immunol. 2008. 181: 4219-4228.
57. Zuber, B., Quigley, M. F., Critchfield, J. W., Shacklett, B. L., Abel, K., Miller, C. J., Morner, A. et al., Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot. J. Immunol. Methods 2006. 312: 45-53.